L-FABP directly interacts with PPARα in cultured primary hepatocytes

Journal of Lipid Research

Volumn 50, Issue 8, 2009, Pages 1663-1675

  Hostetler, Heather A ^a   McIntosh, Avery L ^a   Atshaves, Barbara P ^a   Storey, Stephen M ^a   Payne, H Ross ^a   Kier, Ann B ^a   Schroeder, Friedhelm ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Cytoplasmic lipid binding protein; Fluorescence; FRET; Liver fatty acid binding protein; Nuclei; Peroxisome proliferator activated receptor; Transcription factor

Indexed keywords

FATTY ACID BINDING PROTEIN; LIVER FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; FABP1 PROTEIN, MOUSE; FATTY ACID; LIGAND; PALMITIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ISOLATION; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FATTY ACID METABOLISM; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOELECTRON MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL; LIVER HOMOGENATE; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL NUCLEUS; CHEMISTRY; METABOLISM; MOUSE MUTANT; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN QUATERNARY STRUCTURE; ULTRASTRUCTURE;

ANIMALS; CELL COMPARTMENTATION; CELL NUCLEUS; CELLS, CULTURED; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HEPATOCYTES; LIGANDS; MALE; MICE; MICE, KNOCKOUT; PALMITIC ACID; PPAR ALPHA; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 69449106150     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M900058-JLR200     Document Type: Article

References (42)

1. Francis, G. A., E. Fayard, F. Picard, and J. Auwerx. 2003. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65: 261-311.
2. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator activated receptors: nuclear control of metabolism. Endocr. Rev. 20: 649-688.
3. Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature. 405: 421-424.
4. Green, S., and W. Wahli. 1994. Peroxisome proliferator-activated receptors: finding the orphan a home. [Review] Mol. Cell. Endocrinol. 100: 149-153.
5. Schroeder, F., A. D. Petrescu, H. Huang, B. P. Atshaves, A. L. McIntosh, G. G. Martin, H. A. Hostetler, A. Vespa, K. Landrock, D. Landrock, et al. 2008. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids. 43: 1-17.
6. Hostetler, H. A., A. D. Petrescu, A. B. Kier, and F. Schroeder. 2005. Peroxisome proliferator activated receptor alpha (PPARalpha) interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem. 280: 18667-18682.
7. Lin, Q., S. E. Ruuska, N. S. Shaw, D. Dong, and N. Noy. 1999. Ligand selectivity of the peroxisome proliferator-activated receptor α. Biochemistry. 38: 185-190.
8. Hostetler, H. A., A. B. Kier, and F. Schroeder. 2006. Very-long-chain and branched-chain fatty acyl CoAs are high affi nity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha). Biochemistry. 45: 7669-7681.
9. Hostetler, H. A., H. Huang, A. B. Kier, and F. Schroeder. 2008. Glucose directly links to lipid metabolism through high-affinity interactionwith peroxisome proliferator activated receptor-alpha. J. Biol. Chem. 283: 2246-2254.
10. Elholm, M., I. Dam, C. Jorgenesen, A-M. Krogsdam, D. Holst, I. Kratchamarova, M. Gottlicher, J. A. Gustafsson, R. K. Berge, T. Flatmark, et al. 2001. Acyl CoA esters antagonize the effects of ligands on peroxisome proliferator activated receptor α conformation, DNA binding, and interaction with cofactors. J. Biol. Chem. 276: 21410-21416.
11. Elholm, M., A. Garras, S. Neve, D. Tarnehave, T. B. Lund, J. Skorve, T. Flatmark, K. Kristiansen, and R. K. Berge. 2000. Long chain acyl CoA esters and acyl CoA binding protein are present in the nucleus of rat liver cells. J. Lipid Res. 41: 538-545.
12. Huang, H., O. Starodub, A. McIntosh, B. P. Atshaves, G. Woldegiorgis, A. B. Kier, and F. Schroeder. 2004. Liver fatty acid binding protein colocalizes with peroxisome proliferator receptor alpha and enhances ligand distribution to nuclei of living cells. Biochemistry. 43: 2484-2500.
13. Wolfrum, C., C. M. Borrmann, T. Borchers, and F. Spener. 2001. Fatty acids and hypolipidemic drugs regulate PPARalpha and PPARgamma gene expresion via L-FABP: a signaling path to the nucleus. Proc. Natl. Acad. Sci. USA. 98: 2323-2328.
14. Lawrence, J. W., D. J. Kroll, and P. I. Eacho. 2000. Ligand dependent interaction of hepatic fatty acid binding protein with the nucleus. J. Lipid Res. 41: 1390-1401.
15. Huang, H., O. Starodub, A. McIntosh, A. B. Kier, and F. Schroeder. 2002. Liver fatty acid binding protein targets fatty acids to the nucleus: real-time confocal and multiphoton fluorescence imaging in living cells. J. Biol. Chem. 277: 29139-29151.
16. Atshaves, B. P., A. Petrescu, O. Starodub, J. Roths, A. B. Kier, and F. Schroeder. 1999. Expression and intracellular processing of the 58 kDa sterol carrier protein 2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fi broblasts. J. Lipid Res. 40: 610-622.
17. Murphy, E. J., R. D. Edmondson, D. H. Russell, and F. Schroeder. 1999. Isolation and characterization of two distinct forms of liver fatty acid binding protein from the rat. Biochim. Biophys. Acta. 1436: 413-425.
18. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta(12,14)-prostaglandin J(2) is a ligand for the adipocyte determination factor PPARgamma. Cell. 83: 803-812.
19. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J(2) metabolite binds peroxisome proliferator activated receptor gamma and promotes adipocyte differentiation. Cell. 83: 813-819.
20. Yamamoto, T., H. Shimano, Y. Nakagawa, T. Ide, N. Yagagi, T. Matsuzaka, M. Nakakuki, A. Takahashi, H. Suzuki, H. Sone, et al. 2004. SREBP-1 interacts with HNF4alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J. Biol. Chem. 279: 12027-12035.
21. Wang, X., R. Sato, M. S. Brown, X. Hua, and J. L. Goldstein. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77: 53-62.
22. Petrescu, A. D., H. R. Payne, A. L. Boedeker, H. Chao, R. Hertz, J. Bar-Tana, F. Schroeder, and A. B. Kier. 2003. Physical and functional interaction of acyl CoA binding protein (ACBP) with hepatocyte nuclear factor-4alpha (HNF4alpha). J. Biol. Chem. 278: 51813-51824.
23. Sreerama, N., and R. Woody. 2000. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and DCSSTR methods with an expanded reference set. Anal. Biochem. 287: 252-260.
24. Petrescu, A. D., H. Huang, H. A. Hostetler, F. Schroeder, and A. B. Kier. 2008. Structural and functional characterization of a new recombinant histidine-tagged acyl CoA binding protein (ACBP) from mouse. Protein Expr. Purif. 58: 184-193.
25. Martin, G. G., H. Danneberg, L. S. Kumar, B. P. Atshaves, E. Erol, M. Bader, F. Schroeder, and B. Binas. 2003. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid binding protein (L-FABP) gene. J. Biol. Chem. 278: 21429-21438.
26. Atshaves, B. P., A. L. McIntosh, O. I. Lyuksyutova, W. R. Zipfel, W. W. Webb, and F. Schroeder. 2004. Liver fatty acid binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. J. Biol. Chem. 279: 30954-30965.
27. Philimonenko, A. A., J. Janacek, and P. Hozak. 2000. Statistical evaluation of colocalization patterns in immunogold labeling experiments. J. Struct. Biol. 132: 201-210.
28. Atshaves, B. P., A. L. McIntosh, H. R. Payne, A. M. Gallegos, K. Landrock, N. Maeda, A. B. Kier, and F. Schroeder. 2007. Sterol carrier protein-2/sterol carrier protein-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes. J. Lipid Res. 48: 2193-2211.
29. Stepensky, D. 2007. FRETcalc plugin for calculation of FRET in non-continuous intracellular compartments. Biochem. Biophys. Res. Commun. 359: 752-758.
30. Wouters, F. S., P. I. Bastiaens, K. W. Wirtz, and T. M. Jovin. 1998. FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid oxidation enzymes. EMBO J. 17: 7179-7189.
31. Frolov, A., T. H. Cho, E. J. Murphy, and F. Schroeder. 1997. Isoforms of rat liver fatty acid binding protein differ in structure and affinity for fatty acids and fatty acyl CoAs. Biochemistry. 36: 6545-6555.
32. Martin, G. G., H. A. Hostetler, S. E. Tichy, D. H. Russell, J. M. Berg, G. Woldegiorgis, T. A. Spencer, J. A. Ball, A. B. Kier, and F. Schroeder. 2008. Structure and function of the sterol carrier protein-2 (SCP-2) N-terminal pre-sequence. Biochemistry 47: 5915-5934.
33. Lakowicz, J. R. 2006. Energy transfer. In Principles of Fluorescence Spectroscopy. J. R. Lakowicz, editor. Springer Science, New York. 443-475.
34. Thompson, J., N. Winter, D. Terwey, J. Bratt, and L. Banaszak. 1997. The crystal structure of the liver fatty acid-binding protein. J. Biol. Chem. 272: 7140-7150.
35. Fisher, E., C. Weikert, M. Klapper, I. Lindner, M. Mohlig, J. Spranger, H. Boeing, J. Schrezenmeir, and F. Doring. 2007. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol. Genet. Metab. 91: 278-284.
36. Brouillette, C., Y. Bose, L. Perusse, D. Gaudet, and M-C. Vohl. 2004. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J. Hum. Genet. 49: 424-432.
37. Magnusson, A. L., I. J. Waterman, T. Jansson, and T. L. Powell. 2004. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J. Clin. Endocrinol. Metab. 89: 4607-4614.
38. Engels, W., M. van Bilsen, B. H. R. Wolffenbuttel, G. J. Van der Vusse, and J. F. Glatz. 1999. Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid binding protein content in liver, heart, and kidney of the diabetic rat. Mol. Cell. Biochem. 192: 53-61.
39. Paulussen, R. J. A., and J. H. Verkamp. 1990. Intracellular fatty acid binding proteins: characteristics and function. In Subcellular Biochemistry: Intracellular Transfer of Lipid Molecules. Vol. 16. H. J. Hilderson, editor. Plenum Press, New York.
40. Kamijo-Ikemori, A., T. Sugaya, A. Sekizuka, K. Hirata, and K. Kimura. 2009. Amelioration of diabetic tubulointerstitial damage in liver type fatty acid binding protein transgenic mice. Nephrol. Dial. Transplant. 24: 788-800.
41. Budhu, A. S., and N. Noy. 2002. Direct channeling of retinoic acid between cellular retinoic acid binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid induced growth arrest. Mol. Cell. Biol. 22: 2632-2641.
42. Tan, N-S., N. S. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, B. Desvergne, W. Wahli, and N. Noy. 2002. Selective cooperation between fatty acid binding proteins and peroxisome proliferator activated receptors in regulating transcription. Mol. Cell. Biol. 22: 5114-5127.